Jamie Burba: Author, Filmmaker, Cancer Survivor and Advocate
"What’s next is smart homes where Jamie can control the thermostat, open and close the curtains, and use the iPad to see who’s at the door...There’s so much potential.”...
"What’s next is smart homes where Jamie can control the thermostat, open and close the curtains, and use the iPad to see who’s at the door...There’s so much potential.”...
"Lo que sigue son las casas inteligentes, donde Jamie puede controlar el termostato, abrir y cerrar las cortinas, y usar el iPad para ver quién está en la puerta ...Hay bastante potencial "....
" ...hazlo, para que puedas conservar tus dientes de por vida. He recuperado mi sonrisa y no podría estar más feliz "....
por James O’Hanlon, Ph.D., Psychopharmacologist La mayoría de las personas con TEA sufren algún grado de deterioro del lenguaje expresivo y/ o receptivo. Para personas con funcionamiento superior, puede ser sólo una incapacidad relativa, para comprender...
...Stunningly, a highly significant treatment effect emerged 6 months after treatment had ended. Receptive language skills of the group treated with donepezil plus choline had continued to improve over the ‘washout’ period, whereas those of the placebo...
...Anti-inflammatory drugs are targeted on the pathophysiology of ASD not on behavioral symptoms that occur as consequence. Many of those symptoms are assumed to be caused or at least exacerbated by neuroinflammation. Thus, when a drug successfully reduces...
"...get it done so you can keep your teeth for life. I have my smile back and I couldn’t be...
...Developments that followed publication of this study were also unprecedented. Within a month, two major clinical trials with SFN involving individuals with ASD were commissioned by Governmental agencies. The first will be conducted at Rutgers University to...
...GWP has submitted a New Drug Application to FDA for approval of Epidiolex marketing and prescription for seizure control in Dravet and Lennox-Gastaut syndromes. FDA’s decision is expected this year. GWP is not stopping there. Phase III trials of...
